Saudi Arabia Human Insulin Market By Indication,By Type, By Products, By Region, Forecast 2027
Posted by arshiyashaikh on June 20th, 2022
Saudi Arabia Human Insulin Market is projected to register a robust growth during the forecast period. The growth can be attributed to the rising number of patients suffering from diabetes and growing research & development activities for drug discovery. Insulin is used to manage blood sugar levels in the body and thus reduce the symptoms of diabetes and vascular complications. According to the World Health Organization statistics, Saudi Arabia ranks seventh in the rate of diabetes. The estimates show that 7 million of the country’s population are diabetic while 3 million have pre-diabetic conditions. Increasing awareness of diabetes and advancing healthcare facilities providing treatment for chronic disorders are also propelling the growth of Saudi Arabia human insulin market. The risk of diabetes is likely to increase with growing age, and currently around 25% adults over 60 years suffer from diabetes. Thus, increasing prevalence of geriatric population is also anticipated to fuel the growth of Saudi Arabia human insulin market in the coming years.
Allocation of huge funds for the healthcare, launch of new programs to educate people about diabetics by the government, and technological advancements in the field of human insulin delivery devices are likely to drive the growth of Saudi Arabia human insulin market. However, stringent regulatory requirements for the product approvals as well high manufacturing costs could restrain the growth of Saudi Arabia human insulin market. Besides, the key players are making huge investments to devise effective ways to use insulin and minimize the side-effects, which is expected to contribute to the growth of Saudi Arabia human insulin market.
Browse our full report with Table of Contents:
Contact us at:
Like it? Share it!
About the Authorarshiyashaikh
Joined: February 5th, 2019
Articles Posted: 552
More by this author